UNSPSC 51433913: Clevidipine

This classification denotes a calcium channel blocker with the molecular formula C21H23Cl2NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19O2GP3B7Q, chemically known as 3,5-pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl (1-oxobutoxy)methyl ester but generally known as clevidipine, which bears US NIH Compound Identifier 153994. European Medicines Agency schedules Clevidipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06655MIG.

UNSPSC 51433913 Clevidipine is a Commodity code representing a specific pharmaceutical agent used in emergency and critical care settings. State and local governments purchase clevidipine and related advanced life support medications through their fire rescue departments, emergency medical services, and hospital systems. Clevidipine itself is an intravenous calcium channel blocker used for acute hypertension management in emergency settings, though recent solicitations under this code span a broader range of advanced life support injectable medications including vasopressors, antiarrhythmics, and related emergency pharmaceuticals. Buying bodies soliciting under this code include municipal fire rescue departments, county emergency medical services, public hospital systems, and transit authority medical services units. These purchases are typically framed as commodity-level acquisitions of specific drug formulations in defined unit quantities, with firm pricing, standardized expiration-date requirements, rapid delivery timelines, and warranty provisions covering defect-free status and expired-stock replacement.

Municipal fire rescue departments drive recent activity under this code, with the City of Tampa's Purchasing Department issuing an IFB (Bid No. 26-P-00188) on April 24, 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida. That solicitation required four specific medication line items—Labetalol, Epinephrine, Adenosine, and Diltiazem—with a response deadline of April 8, 2026 (already closed) and an estimated contract value of $40,000.00. The award was to be made to the lowest responsive, responsible bidder within 120 days of bid opening, with a one-year initial term and options for two additional one-year renewals plus three 30-day unilateral extensions. The City applied a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount capped at $10,000. Geographic activity under this code centers on Florida, though the broader Commodity class spans municipal and county emergency services procurement nationally.